Skip to main content

Table 1 General patient information

From: Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements

  Group I (n=53) Group II (n=68) t/χ2 P
Age (years old) 56.43±13.23 62.26±13.00 2.429 0.017
Male (n/%) 40(75.47 %) 56(82.35 %) 0.860 0.241
Male smokers (n/%) 24(45.28 %) 22(39.29 %) 4.012 0.036
History of hypertension (n/%) 30(56.60 %) 34(50.00 %) 0.521 0.295
TG (mmol/L) 2.25±2.04 1.44±0.51 3.991 <0.001
HDL-C (mmol/L) 0.88±0.20 0.91±0.26 -0.745 0.458
LDL-C (mmol/L) 3.05±1.79 2.64±0.87 1.630 0.106
number of low initial LDL-C cases(n/%) 9(16.98 %) 12(17.65 %) 0.009 0.560
apoA-1 (g/L) 1.28±0.20 1.26±0.22 0.563 0.574
apoB (g/L) 1.01±0.48 0.86±0.23 2.329 0.022
Lp(a) (g/L) 344.24±297.91 260.63±207.07 1.701 0.093
Initial skin cholesterol 0.32±0.08 0.31±0.08 0.538 0.592
  1. Low initial LDL-C: LDL-C < 1.8mmol/L at admission